Protein-Truncating Variants at the Cholesteryl Ester Transfer Protein Gene and Risk for Coronary Heart Disease

Therapies that inhibit CETP (cholesteryl ester transfer protein) have failed to demonstrate a reduction in risk for coronary heart disease (CHD). Human DNA sequence variants that truncate the

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Akihiro Nomura, Hong‐Hee Won, Amit V. Khera, Fumihiko Takeuchi, Kaoru Ito, Shane McCarthy, Connor A. Emdin, Derek Klarin, Pradeep Natarajan, Seyedeh M. Zekavat, Namrata Gupta, Gina M. Peloso, Ingrid B. Borecki, Tanya M. Teslovich, Rosanna Asselta, Stefano Duga, Piera Angelica Merlini, Adolfo Correa, Thorsten Kessler, James G. Wilson, Matthew J. Bown, Alistair S. Hall, Peter S. Braund, David J. Carey, Michael F. Murray, H. Lester Kirchner, Joseph B. Leader, Daniel R. Lavage, J. Neil Manus, Dustin N. Hartze, Nilesh J. Samani, Heribert Schunkert, Jaume Marrugat, Roberto Elosúa, Ruth McPherson, Martin Farrall, Hugh Watkins, Jyh‐Ming Jimmy Juang, Chao A. Hsiung, Shih-Yi Lin, Jun‐Sing Wang, Hayato Tada, Masa‐aki Kawashiri, Akihiro Inazu, Masakazu Yamagishi, Tomohiro Katsuya, Eitaro Nakashima, Masahiro Nakatochi, Ken Yamamoto, Mitsuhiro Yokota, Yukihide Momozawa, Jerome I. Rotter, Eric S. Lander, Daniel J. Rader, John Danesh, Diego Ardissino, Stacey Gabriel, Cristen J. Willer, Gonçalo R. Abecasis, Danish Saleheen, Michiaki Kubo, Norihiro Kato, Yii‐Der Ida Chen, Frederick E. Dewey, Sekar Kathiresan
Format: Revisão
Jezik:angleščina
Izdano: 2017
Online dostop:https://doi.org/10.1161/circresaha.117.311145
https://www.ahajournals.org/doi/pdf/10.1161/CIRCRESAHA.117.311145
Oznake: Označite
Brez oznak, prvi označite!